Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.462 EUR | 0.00% |
|
-11.15% | +3.59% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2021 | 44.63K 47.65K | Sales 2022 | 12.23K 13.06K | Capitalization | 5.91M 6.31M |
---|---|---|---|---|---|
Net income 2021 | -4M -4.27M | Net income 2022 | - 0 | EV / Sales 2021 | 429 x |
Net Debt 2021 | 121K 129K | Net cash position 2022 | 1.84M 1.96M | EV / Sales 2022 | 333 x |
P/E ratio 2021 |
-4.68
x | P/E ratio 2022 |
-7.12
x | Employees | 1 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 40.86% |
1 week | -11.15% | ||
Current month | -14.44% | ||
1 month | -20.34% | ||
3 months | +23.53% | ||
6 months | -42.25% | ||
Current year | +3.59% |
![Extreme 0.45](/images/extremecours_fleche.png)
![Extreme 0.43](/images/extremecours_fleche.png)
![Extreme 0.3](/images/extremecours_fleche.png)
![Extreme 0.3](/images/extremecours_fleche.png)
![Extreme 0.3](/images/extremecours_fleche.png)
![Extreme 0.3](/images/extremecours_fleche.png)
![Extreme 0.3](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Bruno Rosen
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ralph Bieneck
BRD | Director/Board Member | 56 | - |
Arne Segler
CHM | Chairman | - | - |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-26 | 0.462 | 0.00% | 0 |
24-06-25 | 0.462 | -3.75% | 5,000 |
24-06-24 | 0.48 | -1.64% | 12,997 |
24-06-21 | 0.488 | -2.01% | 892 |
24-06-20 | 0.498 | -4.23% | 892 |
Delayed Quote Xetra, June 26, 2024 at 11:36 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+3.59% | 2.54M | |
+24.58% | 52.73B | |
+37.49% | 39B | |
-8.89% | 38.52B | |
+27.91% | 30.38B | |
-12.26% | 26.39B | |
+10.35% | 26.08B | |
+44.64% | 14.15B | |
+32.59% | 12.6B | |
-6.59% | 11.51B |
- Stock Market
- Equities
- T5O Stock